| 注册
首页|期刊导航|军事医学|TWEAK及其受体在心血管疾病中的作用研究进展

TWEAK及其受体在心血管疾病中的作用研究进展

洪长江 李全亮 张园

军事医学2016,Vol.40Issue(2):158-161,4.
军事医学2016,Vol.40Issue(2):158-161,4.DOI:10.7644/j.issn.1674-9960.2016.02.020

TWEAK及其受体在心血管疾病中的作用研究进展

Research progress in TWEAK and its receptor functions in cardiovascular diseases

洪长江 1李全亮 2张园1

作者信息

  • 1. 广州军区广州总医院心内科,广州 510010
  • 2. 南方医科大学在读研究生,广州 510515
  • 折叠

摘要

Abstract

Tumor necrosis factor-like weak inducer of apoptosis ( TWEAK ) is a member of the superfamily .TWEAK binds to its receptor [ fibroblast growth factor-inducible 14 ( Fnl4 ) and the serum level of soluble CD 163 ( sCD163 ) ] and regulates many cellular activities via associated signal pathways ,including proliferation,migration,differentiation,apoptosis, angiogenesis and inflammation ,which play a significant role in the formation and development of cardiovascular diseases , such as atherosclerosis , heart failure , cardiomyopathy , and peripheral vascular disease .This review summarizes functions of TWEAK and its receptor in cardiovascular diseases .

关键词

肿瘤坏死因子样弱凋亡诱导因子/心肌梗死/心力衰竭/心肌病/动脉粥样硬化/外周血管疾病/心肌纤维化

Key words

TWEAK/myocardial infarction/heart failure/cardiomyopathy/atherosclerosis/peripheral vascular disease/myocardial fibrosis

分类

医药卫生

引用本文复制引用

洪长江,李全亮,张园..TWEAK及其受体在心血管疾病中的作用研究进展[J].军事医学,2016,40(2):158-161,4.

基金项目

国家自然科学基金资助项目(81402671) (81402671)

军事医学

OA北大核心CSCDCSTPCD

1674-9960

访问量0
|
下载量0
段落导航相关论文